Tilray projects $68M-$75M adjusted EBITDA in fiscal 2027 as it targets margin expansion
retained text
Search fieldHome page Seeking Alpha - Power to InvestorsAbout PremiumCreate free accountSearch for Symbols, analysts, keywordsLog in Earnings Call Insights Tilray projects $68M-$75M adjusted EBITDA in fiscal 2027 as it targets margin expansion Jul 29, 2026, 3:44 AM ETTilray Brands, Inc. (TLRY) Stock, TLRY:CA StockAI-Generated Earnings Calls Insights Earnings Call Insights: Tilray Brands, Inc. (TLRY) Q4 fiscal 2026 Management view "Fiscal 2026 proves something important and exciting. Tilray Brands is more than the company many people think it is." (President, CEO & Chairman Irwin Simon) "Today, Tilray is a diversified global consumer products and pharmaceutical Seeking Alpha's Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. Is this happening to you frequently? Please report it on our feedback forum. If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. Search fieldEntering text into the input field will update the search result belowEntering text into the input field will update the search result below Quick Insights Management emphasizes record revenue and adjusted EBITDA, margin expansion, efficiency improvements, and integrating BrewDog, forecasting higher adjusted EBITDA for fiscal 2027. Management identifies continued international cannabis price compression, Canadian medical cannabis reimbursement changes, and slow U.S. beer brand integration as primary risks to margins and earnings. Management stresses disciplined M&A, entering large states if policy is durable, and states projections don't include federal legalization or rescheduling impacts, prioritizing integration and strong balance sheet. Recommended For You
document fetched 2026-07-29 08:29 · canonical https://seekingalpha.com/news/4620062-tilray-projects-68m-75m-adjusted-ebitda-in-fiscal-2027-as-it-targets-margin-expansion?feed_item_type=news